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Abstract
Motivation:Molecular interaction networks are powerful resources for the discovery. They are increasingly
used with machine learning methods to predict biologically meaningful interactions. While deep learning on
graphs has dramatically advanced the prediction prowess, current graph neural network (GNN) methods are
optimized for prediction on the basis of direct similarity between interacting nodes. In biological networks,
however, similarity between nodes that do not directly interact has proved incredibly useful in the last
decade across a variety of interaction networks.
Results: Here, we present SkipGNN, a graph neural network approach for the prediction of molecular
interactions. SkipGNN predicts molecular interactions by not only aggregating information from direct
interactions but also from second-order interactions, which we call skip similarity. In contrast to existing
GNNs, SkipGNN receives neural messages from two-hop neighbors as well as immediate neighbors in the
interaction network and non-linearly transforms the messages to obtain useful information for prediction.
To inject skip similarity into a GNN, we construct a modified version of the original network, called the skip
graph. We then develop an iterative fusion scheme that optimizes a GNN using both the skip graph and the
original graph. Experiments on four interaction networks, including drug-drug, drug-target, protein-protein,
and gene-disease interactions, show that SkipGNNachieves superior and robust performance, outperforming
existing methods by up to 28.8% of area under the precision recall curve (PR-AUC). Furthermore, we show
that unlike popular GNNs, SkipGNN learns biologically meaningful embeddings and performs especially
well on noisy, incomplete interaction networks.




Molecular interaction networks are ubiquitous in biological systems. Over the last decade, interaction
networks have advanced our systems-level understanding of biology [Cowen et al., 2017]. Further, they have





























Figure 1: Direct versus skip similarity. (Left) Traditionally, an interaction between nodes A and B implies
that A and B are similar and vice versa [McPherson et al., 2001]. (Right) In contrast, in molecular interaction
networks, directly interacting entities are not necessarily similar, which has been observed in numerous
networks, including genetic interaction networks [Costanzo et al., 2010, 2016] and protein-protein interaction
networks [Kovács et al., 2019, Zitnik et al., 2019b].
including drug-target interactions (DTIs) [Luo et al., 2017a], drug-drug interactions (DDIs) [Zitnik et al.,
2018a], protein-protein interactions (PPIs) [Luck et al., 2020], and disease-gene associations (DGIs) [Agrawal
et al., 2018]. To assist in these discoveries, a plethora of computational methods, primarily optimized for
link prediction from networks (e.g., Lei and Ruan [2013]), were developed to predict new interactions in
molecular networks. Recently, deep learning on graphs has emerged as a dominant class of methods that
have revolutionized state-of-the-art in learning and reasoning over network datasets. These methods, often
referred to as graph neural networks (GNNs) [Wu et al., 2019] and graph convolutional networks (GCNs) [Kipf
and Welling, 2017, Veličković et al., 2018], operate by performing a series of non-linear transformations on
the input molecular network, where each transformation aggregates information only from immediate
neighbors, i.e., direct interactors in the network. While these methods yield powerful predictors, they
explicitly take into account only direct similarity between nodes in the network. Therefore, GNNs are
limited at fully capturing important information for prediction that resides further away from a particular
interaction in the network that we want to predict [Abu-El-Haija et al., 2019].
Indirect similarity between nodes that do not directly interact, e.g., the similarity in second-order inter-
actions, has proved incredibly useful across a variety of molecular networks, including genetic interaction
and protein-protein interaction networks [Costanzo et al., 2010, 2016, Zitnik et al., 2019b, Kovács et al., 2019].
This is because interactions can exist between nodes that are not necessarily similar, as illustrated in Figure 1.
For example, in a drug-target interaction (DTI) network, an edge indicates that a drug binds to a target
protein. Thus, two drugs are similar because they bind to the same target protein. In contrast, a drug and
a target protein are not biologically similar, although they are connected by an edge in the DTI network.
This example illustrates the importance of second-order interactions, which we refer to as skip similarity
(Figure 1). For this reason, we need GNNs to predict molecular interactions, not only via direct interactions
but also via similarity in second-order interactions.
Present work. Here, we present SkipGNN, a graph neural network (GNN) method for the prediction of
molecular interactions. In contrast to existing GNNs, such as GCN [Kipf and Welling, 2017], SkipGNN
specifies a neural architecture, in which neural messages are passed not only via direct interactions, referred
to as direct similarity, but also via similarity in second-order interactions, referred to as skip similarity
(Figure 1). Importantly, while the principle of skip similarity governs many types of molecular interaction
networks, popular GNNmethods fail to capture the principle. Because of that, as we show here, they cannot
fully utilize molecular interaction networks. SkipGNN takes as input a molecular interaction network and
uses it to construct a skip graph. This second-order network representation captures the skip similarity.
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SkipGNN then uses both the original graph (i.e., the input interaction network) and the skip graph to learn
what is the best way to propagate and transform neural messages along edges in each graph to optimize for
the discovery of new interactions.
We evaluate SkipGNN on four types of interaction networks, including two homogeneous networks,
i.e., drug-drug interaction and protein-protein interaction networks, and two heterogeneous networks,
i.e., drug-target interaction and gene-disease interaction networks. SkipGNN outperforms baselines that
use random walks, shallow network embeddings, spectral clustering, and network metrics by up to 28.8%
in PR-AUC [Perozzi et al., 2014, Grover and Leskovec, 2016, Ribeiro et al., 2017, Tang and Liu, 2011, Kovács
et al., 2019]. Further, the method shows a 7.9% improvement in PR-AUC over state-of-the-art graph neural
networks [Kipf and Welling, 2017, 2016].
By examining SkipGNN’s performance in increasingly harder prediction settings when large fractions
of interactions are removed from the network, we find that SkipGNN achieves robust performance. In
particular, across all interaction networks, SkipGNN consistently outperforms all baseline methods, even
when interaction networks are highly incomplete (Section 5.1-5.2). We find that the robust performance of
SkipGNN can be explained by the spectral property of skip graph, as it can preserve network structure in the
face of incomplete interaction information (Section 5.3), which is also confirmed experimentally (Section 5.5).
Further, we examine embeddings learned by SkipGNN and find that SkipGNN learns biologically
meaningful embeddings, whereas a regular GCN does not (Section 5.4). For example, when analyzing a
drug-target interaction network, SkipGNN generates the embedding space in which drugs are generally
separated from most of proteins while still being positioned close to the proteins to which they directly bind.
Lastly, in the case of the drug-drug interaction network, we use the literature search to find evidence for
SkipGNN’s novel drug-drug interaction predictions (Section 5.6).
2 Related work
Related work on link prediction. Existing link prediction methods belong to one of the following
categories. (1) Heuristic or mechanistic methods (e.g., Lü and Zhou [2011], Menche et al. [2015], Durán et al.
[2018], Kovács et al. [2019]) calculate an index similarity score to measure the probability of a link given
the network structure around the two target nodes, such as Preferential Attachment (PA) [Barabási and
Albert, 1999] and Local Path Index (LP) [Lü et al., 2009]. However, these methods usually make strong
assumptions about the network structure and hence suffer from instability of performance [Lü and Zhou,
2011, Kovács et al., 2019]. (2) Direct embedding methods generate embeddings for every node in the network
capturing the node’s local network topology (e.g., Zitnik and Zupan [2015], Wang et al. [2018], Xu et al. [2019]).
A popular approach is to use random walks with a skip-gram model, such as DeepWalk [Perozzi et al., 2014],
node2vec [Grover and Leskovec, 2016], and LINE [Tang et al., 2015]. The other popular approach leverages
the spectral graph theory to generate a spectral embedding such as spectral clustering [Tang and Liu, 2011].
The generated node embeddings are then fed into a decoder classifier to predict the link existing probability.
(3) Neural embedding methods, such as Graph Neural Networks (GNNs) [Kipf and Welling, 2017, Hamilton
et al., 2017], Variational Graph Autoencoders (VGAE) [Kipf and Welling, 2016, Ma et al., 2018], and Graph
Attention Networks (GAT) [Veličković et al., 2018] use neighborhood message passing scheme to generate
node embeddings and these embeddings are directly optimized in an end-to-end manner by a link prediction
loss (e.g., cross-entropy). GNN-based methods have been shown to achieve state-of-the-art performance
across a variety of network datasets [Zhang and Chen, 2018, Kipf and Welling, 2016]. SkipGNN further
improves GNN-based methods by capturing the skip similarity that other GNN-based methods are incapable
of capturing.
Related work on molecular interaction prediction. In molecular interaction networks, the goal is to
predict if a given pair of biomedical entities such as proteins, drugs or diseases will interact. We can divide
methods for interaction prediction into three main groups. (1) Structural representation learning generates
embeddings for each entity using the entity’s structural representation, such as a compound’s molecular graph
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or a protein’s amino acid sequence. The embeddings of two entities are then combined and fed into a decoder
for prediction. For example, Tsubaki et al. [2019], Öztürk et al. [2018], Gao et al. [2018] use graph-convolutional
(GCN) and convolutional (CNN) networks on molecular graphs and gene sequence data to predict binding
of drugs to target proteins. Similarly, Huang et al. [2020], Ryu et al. [2018], Cheng and Zhao [2014] learn
embedding for drugs and concatenate embeddings of drug pairs to predict drug-drug interactions. (2)
Similarity-based learning is based on the assumption that entities with similar interaction patterns are likely
to interact. These methods devise a similarity measure (e.g., a graphlet-based signature of proteins in the PPI
network [Milenković and Pržulj, 2008]) and then use the measure to predict interactions based on how similar
a candidate interaction is to known interactions. A variety of techniques are used to aggregate similarity
values and score interactions, including matrix factorization [Zhang et al., 2018], clustering [Ferdousi et al.,
2017], and label propagation [Zhang et al., 2015]. (3) Finally, network relational learning views the task as a
network completion problem. It uses network structure together with side information about nodes to
complete the network and predict interactions [Zitnik et al., 2018a, Ma et al., 2018, Zitnik and Leskovec, 2017].
SkipGNN belongs to the structural representation learning category.
Background on Graph Neural Networks (GNNs). Next, we describe graph neural networks as they are
state-of-the-art models for link prediction and are also the focus of our study. The input to a GNN is the
network, represented by its adjacency matrix A. Most often, the goal (output) of the GNN is to learn an
embedding for each node in the network by capturing the network structure as well as node attributes.
GNN can be represented as a series of neighborhood aggregations layers (e.g., Kipf and Welling [2017]):
H(l+1) = σ (D˜− 12 A˜D˜− 12H(l)W), where H(l) is a matrix of node embeddings at the l-th layer, H(0) are input
node attributes,W is a trainable parameter matrix, σ is a non-linear activation function, and D˜ and A˜ are
the renormalized degree and adjacency matrices, defined as: A˜ = A + I and D˜ii =
∑
j A˜ij (I is the identity
matrix). The GNN propagates information across network neighborhoods and transforms the information
in a way that is most useful for a downstream prediction tasks, such as link prediction. However, GNN is
limited at capturing skip similarity, where SkipGNN utilizes an additional skip-graph to fully exploit this
important quality for biomedical interaction network.
3 Methods
SkipGNN is a graph neural network uniquely suited for molecular interactions. SkipGNN takes as input a
molecular interaction network and uses it to construct a skip graph, which is a second-order network repre-
sentation capturing the skip similarity. SkipGNN then specifies a novel graph neural network architecture
that fuses the original and the skip graph to accurately and robustly predict new molecular interactions.
Problem formulation. Consider an interaction network G on N nodes representing biomedical entities
V (e.g., drugs, proteins, or diseases) and M edges E representing interactions between the entities. For
example, G can be a drug-target interaction network recording information on how drugs bind to their
protein targets [Luo et al., 2017b]. For every pair of entities i and j, we denote their interaction with a binary
indicator eij ∈ {0, 1}, indicating the experimental evidence that i and j interact (i.e., eij = 1) or the absence of
evidence for interaction (i.e., eij = 0). We denote the adjacency matrix of G as A, where Aij is 1 if nodes i and
j are connected (eij = 1) in the graph and otherwise 0 (eij = 0). Further,D is the degree matrix, a diagonal
matrix, whereDii is the degree of node i.
Problem (Molecular Interaction Prediction). Given a molecular interaction network G = (V, E), we aim to
learn a mapping function f : E→ [0, 1] from edges to probabilities such that f (i, j) optimizes the probability that
nodes i and j interact.
3.1 Construction of the skip graph
Next, we describe skip graphs, the key novel representation of interaction networks that allow for effective
use of GNNs for predicting interactions. We realize Skip similarity by encouraging the GNNmodel to embed
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Figure 2: Neural architecture of SkipGNN. (Left) SkipGNN constructs skip graphGs (denoted by adjacency
matrix As) based on the input graph G (denoted by adjacency matrix A) using Eq. (1). (Middle) Initial node
embeddings,H(0) and S(0), are specified using side information (e.g., gene expression vectors if nodes represent
genes) or generated using node2vec [Grover and Leskovec, 2016]. In SkipGNN, node embeddings are then
propagated along edges of Gs and G and transformed through a series of computations (layers), which output
powerful embeddings that can then be used for downstream prediction of interactions. Illustrated is a two-
layer iterative fusion scheme. In the first layer, two GNNs with parameter weight matricesW(0)o andW
(0)
s




s based on Eq. (2, 3). This
completes computations in the first layer of SkipGNN, producing embeddings H(1) and S(1). In the second
layer, those embeddings are transformed viaW(1)o andW
(1)
s using Eq. (4), resulting in final embeddings E.
(Right) Embeddings Ei and Ej of target nodes i and j are retrieved, concatenated, and then fed into a decoder
(parameterized byWd). Decoder returns pij, representing the probability that nodes i and j interact.
skipped nodes close together in the embedding space. To do that, we construct skip graph Gs, in two-hop
neighbors are connected by edges. This construction creates paths in Gs along which neural messages can be
exchanged between the skipped nodes.
Formally, we use the following operator to obtain the skip graph’s adjacency matrix As:
Aijs =
{
1 if ∃ k s.t. (i, k) ∈ Eand (k, j) ∈ E
0 otherwise.




s . An efficient way to implement the skip graph is through
matrix multiplication:
As = sign(AAT), (1)
where: sign(x) is the sign function, sign(x) = 1 if x > 0 and 0 otherwise, which is applied element-wise on
AAT. It counts the number of two-hop paths from node i to j. Hence, if an entry for node i, j in AAT is larger
than 0, it means there exists a skipped node between node i, j. Then, we convert the positive entry into 1 to
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Table 1: Notation used in SkipGNN.
Notation Definition
G : {V, E} Graph with nodes Vand edges E
D,A ∈ ZN×N Degree and adjacency matrices for graph G
D˜, A˜ ∈ ZN×N Normalized degree and adjacency matrices for G
X ∈ RN×D D-dimensional node embeddings
eij ∈ {0, 1} Ground-truth interaction between nodes i and j
Gs Skip graph
Ds,As ∈ ZN×N Degree and adjacency matrices for Gs
D˜s, A˜s ∈ RN×N Normalized degree and adjacency matrices for Gs
H(l), S(l) Node embeddings for G and Gs, in layer l
E Final node embeddings
pij ∈ [0, 1] Probability of interaction between nodes i and j
yij ∈ {0, 1} Binary indicator of interaction between nodes i and j
L ∈ R Binary classification loss
W(l)o ,W
(l)
s Weight matrix for original (o) and skip (s) graphs, layer l
W
′(l)
o Weight matrix for skip-to-original-graph fusion
W
′(l)
s Weight matrix for original-to-skip-graph fusion
Wd, b Decoder weight matrix and bias parameter
construct the skip graph’s adjacent matrix. Given this skip graph, we proceed to describe the full SkipGNN
model.
3.2 The SkipGNNmodel
In this section, we describe how we leverage the skip graph for link prediction. After we generate the novel
skip graph from Section 3.1, we propose an iterative fusion scheme for SkipGNN to allow the skip graph
and the original graph to learn from each other for better integration. Lastly, a decoder is used to output a
probability measuring if the given pair of molecular entities interact.
3.2.1 Iterative fusion
We want a model to automatically learn how to balance between direct similarity and skip similarity in the
final embedding. We design an iterative fusion scheme with aggregation gates to combine both similarity
information. The motivation is that to represent biomedical entity to its fullest extent, node embedding
must capture its complicated bioactive functions with skip/direct similarities. Hence, instead of simply
concatenating the output node embeddings from the GNN output of the original graph G that captures
direct similarity and skip graph Gs that captures skip similarity, we allow two GNNs on G and Gs to interact
with each other iteratively via the following propagation rules (see Figure 3):
H(l+1) = σ (AGG(FH(l)W(l)o , FsS(l)W
′(l)
o )) (2)














Here, H(l), S(l) is node embeddings at the l-th layer from direct similarity graph G and skip similarity graph







s are the transformed weights for layer l. H(0) and S(0) are set to be X,
the input node attributes generated from node2vec. The aggregate gate AGG in Eq. (2-3) can be a summation,
a Hadamard product, max-pooling, or some other aggregation operator [Cao et al., 2020]. Empirically, we find
that summation gate has the best performance. σ () is the activation function and we use ReLU(·) = max(·, 0)
to add non-linearity in the propagation.
In each iteration, the node embedding for original graph H(l+1) is first updated with its previous layer’s
node embedding H(l), combined with skip graph embedding S(l). After obtaining the updated original graph
embedding H(l+1), we then update the skip graph embedding S(l+1) in a similar fashion.
This update rule is very different from simple concatenation as it is an iterative process where each
update of the node embedding for each graph is affected by the most recent node embedding from both
graphs. This way, two embedding are learned to find the best dependency structure between each other and
fuse into one final embedding instead of a simple concatenation. In the last layer, final node embedding E is
obtained through:
E = AGG(FH(Lmax)W(Lmax)o , FsS(Lmax)W(Lmax)s ), (4)
where Lmax is the last layer index. As in the motivation, we are interested only in up to second order
neighbors, we set Lmax = 1, see Figure 3. We don’t use activation function here as it does not require an extra
non-linear transformation to be fed into the decoder network. Empirically, we show this fusion scheme
boosts predictive performance in Section 5.5.
3.2.2 SkipGNN decoder
Given the target nodes (i, j) and their corresponding node embedding Ei,Ej, we implement a neural network
as a decoder to first combine Ei,Ej to obtain an input embedding through a COMB function (e.g., concate-
nation, sum, Hadamard product). Then, the combined embedding is fed into a neural network parametrized
by weightWd and bias b as a binary classifier to obtain probability pij:
pij = σ (WdCOMB(Ei,Ej) + b), (5)
where pij represents the probability that nodes i and j interact (i.e., f (i, j). We use concatenation as the
COMB function as it consistently yield the best performance across different types of networks.
3.3 The SkipGNN algorithm
The overall algorithm is shown in Algorithm 1. Here, we only leverage accessible network information
(adjacent matrix A of the network G) to predict links. In all experiments, we initialize embeddings using
node2vec [Grover and Leskovec, 2016] as: X = node2vec(A).
Second, we construct the skip graph with adjacent matrix As via Eq. (1) to capture the skip-similarity
principle. Next, at every step, a mini-batch of interaction pairsMwith labels y is sampled. Then, two graph
convolutions networks are used for the original graph and the skip graph respectively. In the propagation
step, we use iterative fusion (Eq. (2), Eq. (3)) to naturally combine embeddings convolved on the original graph
and on the skip graph, corresponding to direct and skip similarity, respectively. In the last layer, embeddings
are stored in E. We then retrieve the embeddings for each node in the mini-batched pairsMand concatenate
them to feed into decoder (Eq. (5)).






s ,Wd , b in an end-to-end
manner through a binary classification loss: L =
∑
(i, j)∈M yij log pij + (1 − yij) log (1 − pij), where yij is
the true label for nodes i and j that are sampled during training via mini-batching, (i, j) ∈ M, andM is a
mini-batch of interaction pairs. After the model is trained, it can be used to make predictions. Given two
entities i and j, the model predicts probability f (i, j) that i and j interact.
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Algorithm 1: The SkipGNN Algorithm
Input: interaction network G with adjacent matrix A
Node Embedding Generation, e.g.:
X← node2vec(A)
Skip Graph Construction (Section 3.1):
As ← SkipGraph(A) via Eq. (1)
for t = 1 . . .Tmax do
sample mini-batch of training node pairsM ⊆ Ewith corresponding labels y
for l = 0 . . . (Lmax − 1) do
Iterative Fusion (Section 3.2.1):
H(l+1) ← FusionGate(H(l)) via Eq. (2)
S(l+1) ← FusionGate(S(l)) via Eq. (3)
E← FuseGate(H(Lmax), S(Lmax)) via Eq. (4)
Decoder (Section 3.2.2):
pij ← decode(E) via Eq. (5)
Compute the loss valueLusing pij and y (Sec. 3.3) and update model parameters via gradient
descent
4 Data and experimental setup
Next we provide details on molecular interaction datasets, baseline methods, and experimental setup.
4.1 Molecular interaction networks
We consider four publicly-available network datasets. (1) BIOSNAP-DTI [Zitnik et al., 2018b] contains 5,018
drugs that target 2,325 protein through 15,139 drug-target (DTI) interactions. (2) BIOSNAP-DDI [Zitnik et al.,
2018b] consists of 48,514 drug-drug interactions (DDIs) between 1,514 drugs extracted from drug labels and
biomedical literature. (3) HuRI-PPI [Luck et al., 2019] is the human reference protein-protein interaction
network generated by multiple orthogonal the high-throughput yeast two-hybrid screens. We use HI-III
network, which has 5,604 proteins and 23,322 interactions. (4) Finally, we consider DisGeNET-GDI [Piñero
et al., 2019] collects curated disease-gene associations (GDIs) fromGWAS studies, animal models and scientific
literature. The dataset has 81,746 interactions between 9,413 genes and 10,370 diseases.
4.2 SkipGNN implementation and hyperparameters
We implemented SkipGNN using PyTorch deep learning framework1. We use a server with 2 Intel XeonE5-
2670v2 2.5GHZ CPUs, 128GB RAM and 1 NVIDIA Tesla P40 GPU. We set optimization parameters as follows:
learning rate is 5e-4 using the Adam optimizer [Kingma and Ba, 2014], mini-batch size is |M| = 256, epoch
size is 15, and dropout rate is 0.1. We set hyper-parameters using grid search based on best average prediction
performance on validation set. Specifically, we use Lmax = 1, hidden size in the first layer as d(1) = 64 and
hidden size in the second layer as d(2) = 16.
4.3 Baseline methods
We compare SkipGNN to seven powerful predictors of molecular interactions from network science and
graph machine-learning fields.
1The source code implementation of SkipGNN is available at https://github.com/kexinhuang12345/SkipGNN.
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Table 2: Data statistics. ‘A’ indicates average node degree.
Dataset Prediction task # nodes # edges A
DTI Drug-target interaction 7,343 15,139 4.12
DDI Drug-drug interaction 1,514 48,514 64.09
PPI Protein-protein interaction 5,604 23,322 8.32
GDI Disease-gene interaction 19,783 81,746 8.26
From machine learning, we use three direct network embedding methods: DeepWalk [Perozzi et al.,
2014], node2vec [Grover and Leskovec, 2016], and we also include struc2vec [Ribeiro et al., 2017]. The
latter method is conceptually distinct by leveraging local network structural information, while the former
methods use random walks to learn embeddings for nodes in the network. Further, we examine two graph
neural networks: VGAE [Kipf and Welling, 2016] and GCN [Kipf and Welling, 2017]. From network science,
we consider Spectral Clustering [Tang and Liu, 2011]. We also use L3 [Kovács et al., 2019] heuristic, which
was recently shown to outperform over 20 network science methods for the problem of PPI prediction.
Further details on baseline methods, their implementation and parameter selection are in supplementary.
4.4 Experimental setup
In all our experiments, we follow an established evaluation strategy for link prediction (e.g., Zhang and Chen
[2018], Zitnik et al. [2018a]). We divide each dataset into train, validation, and test sets in a 7:1:2 ratio, which
yields positive examples (molecular interactions). We generate their negative counterparts by sampling
the complement set of positive examples. For every experiment, we conduct five independent runs with
different random splits of the dataset. We select the best performing model based on the loss value on the
validation set. The performance of selected model is calculated on the test set. To calculate prediction
performance, we use: (1) area under precision-recall curve (PR-AUC): PR-AUC =
∑n
k=1 Prec(k)ΔRec(k),
where k is k-th precision/recall operating point (Prec(k),Rec(k)); and (2) area under the receiver operating
characteristics curve (ROC-AUC): ROC-AUC =
∑n
k=1 TP(k)ΔFP(k), where k is k-th true-positive and false-
positive operating point (TP(k), FP(k)). Higher values of PR-AUC and ROC-AUC indicate better predictive
performance.
5 Results
Next, we conduct a variety of experiments to investigate the predictive power of SkipGNN (Section 5.1). We
then study the method’s robustness to noise and missing data (Section 5.2 and Section 5.3) and demonstrate
the skip similarity principle (Section 5.4). Next, we conduct ablation studies to examine contributions of each
of SkipGNN’s components towards the final SkipGNN performance (Section 5.5). Finally, we investigate
novel predictions made by SkipGNN (Section 5.6).
5.1 Predicting molecular interactions
We start by evaluating SkipGNN on four distinct types of molecular interactions, including drug-target
interactions, drug-drug interactions, protein-protein interactions, and gene-disease associations, and we
then compare SkipGNN’s performance to baseline methods.
In each interaction network, we randomly mask 30% interactions as the holdout validation (20%) and test
(10%) sets. The remaining 70% interactions are used to train the SkipGNN and each of the baselines. After
training, each method is asked to predict whether pairs of entities in the test set will likely interact.
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Table 3: Predictive performance. SkipGNN achieves the best performance across all metrics and tasks
compared to baselines. Results of five independent runs on DDI, PPI and DTI tasks on state of the art link
prediction algorithms.
Task Method PR-AUC ROC-AUC
DTI
DeepWalk 0.753 ± 0.008 0.735 ± 0.009
node2vec 0.771 ± 0.005 0.720 ± 0.010
struc2vec 0.677 ± 0.007 0.656 ± 0.010
SC 0.818 ± 0.007 0.743 ± 0.008
L3 0.891 ± 0.004 0.793 ± 0.006
VGAE 0.853 ± 0.010 0.800 ± 0.010
GCN 0.904 ± 0.011 0.899 ± 0.010
SkipGNN 0.928 ± 0.006 0.922 ± 0.004
DDI
DeepWalk 0.698 ± 0.012 0.712 ± 0.009
node2vec 0.801 ± 0.004 0.809 ± 0.002
struc2vec 0.643 ± 0.012 0.654 ± 0.007
SC 0.749 ± 0.009 0.816 ± 0.006
L3 0.860 ± 0.004 0.869 ± 0.003
VGAE 0.844 ± 0.076 0.878 ± 0.008
GCN 0.856 ± 0.005 0.875 ± 0.004
SkipGNN 0.866 ± 0.006 0.886 ± 0.003
PPI
DeepWalk 0.715 ± 0.008 0.706 ± 0.005
node2vec 0.773 ± 0.010 0.766 ± 0.005
struc2vec 0.875 ± 0.004 0.868 ± 0.006
SC 0.897 ± 0.003 0.859 ± 0.003
L3 0.899 ± 0.003 0.861 ± 0.003
VGAE 0.875 ± 0.004 0.844 ± 0.006
GCN 0.909 ± 0.002 0.907 ± 0.006
SkipGNN 0.921 ± 0.003 0.917 ± 0.004
GDI
DeepWalk 0.827 ± 0.007 0.832 ± 0.003
node2vec 0.828 ± 0.006 0.834 ± 0.003
struc2vec 0.910 ± 0.006 0.909 ± 0.005
SC 0.905 ± 0.002 0.863 ± 0.003
L3 0.899 ± 0.001 0.832 ± 0.001
VGAE 0.902 ± 0.006 0.873 ± 0.009
GCN 0.909 ± 0.002 0.906 ± 0.006
SkipGNN 0.915 ± 0.003 0.912 ± 0.004
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Figure 3: Predictive performance as a function of network incompleteness. SkipGNN provides robust
result in varying fraction of missing edges. Five-fold average with 95% confidence interval for PR-AUC against
various fractions of missing edges on four prediction tasks: drug-target interaction prediction (DTI), drug-
drug interaction prediction (DDI), protein-protein interaction prediction (PPI) and gene-disease interaction
prediction (GDI) on node2vec, Spectral Clustering (SC), Variational Graph Auto-Encoder (VGAE), Graph
Convolutional Network (GCN), and SkipGNN. We omit DeepWalk as it has similar performance as node2vec.
SKIP-GCN consistently shows the best performance even when networks are highly incomplete.
We report results in Table 4.3. We see that SkipGNN has outperforms all baseline methods across all
molecular interaction networks. Specifically, we see up to 2.7% improvement of SkipGNN over GCN and
up to 8.8% improvement over VGAE on PR-AUC. While GCN and VGAE can only use direct similarity, this
finding provides evidence that considering skip similarity and direct similarity together, as is made possible
by SkipGNN, is important to be able to accurately predict a variety of molecular interactions. Compared to
direct embedding methods, SkipGNN has up to 28.8% increase over DeepWalk, 20.4% increase over node2vec,
and 15.6% over spectral clustering on PR-AUC. These results support previous observations [Zitnik et al.,
2018a] that graph neural networks can learn more powerful network representations than direct embedding
methods. Finally, all baselines vary in performance across datasets/tasks while SkipGNN consistently yields
the most powerful predictor.
5.2 Robust learning on incomplete interaction networks
Next, we test SkipGNN’s performance on incomplete interaction networks. Due to knowledge gaps in
biology, many of today’s interaction networks are incomplete and thus it is crucial that methods are robust
and able to perform well even when many interactions are missing.
In this experiment, we let each method be trained on 10%, 30%, 50%, and 70% of edges in the DTI, DDI, and
PPI datasets and predict on the rest of the data (we use 10% of test edges as validation set for early stopping).
Results in Figure 3 show that SkipGNN gives the most robust results among all the methods. In all tasks,
SkipGNN achieves strong performance even when having access to only 10% of the interactions. Further,
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Figure 4: The ability of skip graph and original graph to capture the network structure in the face of
incomplete data. Skip graph can better preserve the network structure than the original graph, as evidenced
by skip graph’s smaller relative error (Section 5.2) than that of the original graph. This is true for all % of
missing edges, indicating that skip graph can keep useful information about interaction structure even when
networks are highly incomplete and many interactions are missing.
in almost every percentage point, SkipGNN is better than the baselines. In addition, we see that VGAE is
not robust as its performance dropped to around 0.5 PR-AUC in highly-incomplete settings on DTI and
DDI tasks. Performance of node2vec and GCN steadily improve as the percentage of seen edges increases.
Further, while spectral clustering is robust to incomplete data, its performance varies substantially with
tasks. We conclude that SkipGNN is robust and is especially appropriate for data-scarce networks.
5.3 Skip graph better captures noisy molecular interactions
So far, we found that SkipGNN has robust performance on incomplete interaction networks and next we
investigate what makes SkipGNN to perform so robustly. We hypothesize that SkipGNN is robust because
its skip graphs can preserve the graph topology much better than original graphs and this feat becomes
prominent when interaction data are scarce. Note that SkipGNN uses the skip graph whereas other methods
only use the original graph.
To test the hypothesis, we measure the relative error between the original graph G and the incomplete
graphGp in which edges are missing at rate p. We use a metric that calculates the relative error of the spectral
norm for the graph Laplacian matrix: Err(A, p) = (‖L‖2 − ‖Lp‖2)/‖L‖2, where L = A−D, Lp = Ap −Dp, A
(Ap) is adjacency matrix of G (Gp), ‖ · ‖2 = σmax(·), the σmax is the largest singular value [Chung and Graham,
1997].
Figure 4 shows the relative error Err of original and skip graphs against 100 fractions p of missing edges
on the DDI task. We see that the skip graph’s relative error is much lower than that of original graph in
almost all settings. This observation provides evidence for our hypothesis, confirming that skip graphs can
better capture the graph topology than original graphs. Because of that, SkipGNN can learn high-quality
embeddings even when interaction data are scarce.
5.4 SkipGNN learns meaningful embedding spaces
Next, we visualize embeddings learned by GCN and SkipGNN in an effort to investigate whether SkipGNN
can better capture the structure of interaction networks than GCN. For that, we use DTI and GDI networks
in which drugs/diseases are linked to associated proteins/genes. We use t-SNE [Maaten and Hinton, 2008]
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SkipGNNGCN
Figure 5: Visualizations of drug-target interaction network. GCN does not distinguish drug and target
gene as it only captures direct similarity whereas SkipGNN is able to distinct drug and target gene embeddings,
confirming its ability to capture skip similarity. We use GCN and SkipGNN on the drug-target interaction
dataset to learn drug/target embeddings, which are visualized using t-SNE.
GCN SkipGNN
Figure 6: Visualizations of gene-disease interaction network. GCN does not distinguish disease and
gene as it only captures direct similarity whereas SkipGNN is able to distinct disease and gene embeddings,
confirming its ability to capture skip similarity. We use GCN and SkipGNN on the gene-disease interaction
dataset to learn gene/disease embeddings, which are visualized using t-SNE.
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Table 4: Results of ablation experiments. SkipGNN ’s model components setup achieve the best result.
Ablation study result of five independent runs on DDI, PPI and DTI tasks.
Task Method PR-AUC ROC-AUC
DTI
SkipGNN 0.928 ± 0.006 0.922 ± 0.004
-fusion 0.909 ± 0.011 0.907 ± 0.013
-skipGraph 0.904 ± 0.011 0.899 ± 0.010
-Weighted-L1 0.927 ± 0.013 0.926 ± 0.011
-Hadamard 0.796 ± 0.116 0.795 ± 0.116
DDI
SkipGNN 0.866 ± 0.006 0.886 ± 0.003
-fusion 0.864 ± 0.007 0.884 ± 0.002
-skipGraph 0.856 ± 0.005 0.875 ± 0.004
-Weighted-L1 0.863 ± 0.006 0.885 ± 0.003
-Hadamard 0.833 ± 0.054 0.883 ± 0.003
PPI
SkipGNN 0.921 ± 0.003 0.917 ± 0.004
-fusion 0.912 ± 0.004 0.906 ± 0.005
-skipGraph 0.909 ± 0.002 0.907 ± 0.006
-Weighted-L1 0.917 ± 0.003 0.908 ± 0.006
-Hadamard 0.909 ± 0.025 0.914 ± 0.010
GDI
SkipGNN 0.915 ± 0.003 0.912 ± 0.004
-fusion 0.896 ± 0.029 0.892 ± 0.014
-skipGraph 0.909 ± 0.002 0.906 ± 0.006
-Weighted-L1 0.913 ± 0.009 0.898 ± 0.010
-Hadamard 0.883 ± 0.041 0.891 ± 0.025
and visualize the learned embeddings in Figure 5 (DTI network) and Figure 6 (GDI network).
First, we observe that GCN cannot distinguish between different types of biomedical entities (i.e., drugs
vs. proteins and disease vs. genes). In contrast, SkipGNN can successfully separate the entities, as evidenced
by distinguishable groups of points of the same color in the t-SNE visualizations. This observation confirms
that SkipGNN has a unique ability to capture the skip similarity whereas GCN cannot. This is because GCN
forces embeddings of connected drug-protein/gene-disease pairs to be similar and thus it embeds those pairs
close together in the embedding space. However, by doing so, GCN conflates drugs with proteins and genes
with diseases. In contrast, SkipGNN generates a biologically meaningful embedding space in which drugs
are distinguished from proteins (or, genes from diseases) while drugs are still positioned in the embedding
space close to proteins to which they bind (or, in the case of GDI network, diseases are positioned close to
relevant disease-associated genes).
Further, we find that GCN and its graph convolutional variants cannot capture skip similarity because
they aggregate neural messages only from direct (i.e., immediate) neighbors in the interaction network.
SkipGNN solves this problem by passing and aggregating neural message from direct as well as in-direct
neighbors, thereby explicitly capturing skip similarity.
5.5 Ablation studies
To show that each component of SkipGNN has an important role in the final performance of SkipGNN,
we conduct a series of ablation studies. SkipGNN has four key components, and we study how the metho
performance changes when we remove each of the components:
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Table 5: Novel predictions of drug-drug interactions. Shown are top-10 predicted drug-drug interactions
together with the relevant literature providing evidence for predictions.
Rank Drug 1 Drug 2 Evidence for DDI
1 Warfarin Clozapine Mukku et al. [2018]
2 Warfarin Ivacaftor Robertson et al. [2015]
3 Phenelzine Deferasirox
4 Warfarin Paraldehyde DuPont [2000]
5 Warfarin Cyclosporine Snyder [1988]
6 Phenytoin Sipuleucel-T
7 Warfarin Netupitant
8 Phenelzine Suvorexant Merck [2014]
9 Leuprolide Picosulfuric acid
10 Deferasirox Bexarotene Ligand [1999]
• -fusion removes SkipGNN’s fusion scheme and replaces it with a simple concatenation of node
embeddings generated by GCN.
• -skipGraph removes skip graph and degenerates to GCN.
• -Weighted-L1 uses weighted-L1 gate in Eq. (2) as AGG(A, B) = |A− B|, where | · | is the absolute value
operator.
• -Hadamard replaces the summation gate with Hadamard operator ‘∗‘ in Eq. (2) such that AGG(A, B) =
A ∗ B.
Table 5.5 show results of deactivating each of these components, one at a time. Wefind that -fusion outperforms
-skipGraph (i.e., GCN) by a large margin. This finding identifies skip graph as a key driver of performance
improvement. Further, we find that our iterative fusion scheme is important, indicating that successful
methods need to integrate both direct and skip similarity in interaction networks. Next, we see that weighted
L1 gate has comparable or worse performance than the summation gate andHadamard operator performs the
worst, suggesting that SkipGNN’s summation gate is the best-performing aggregation function. Altogether,
we conclude that all SkipGNN’s components are necessary for its strong performance.
5.6 Investigation of SkipGNN’s novel predictions
The main goal of link prediction on graphs is to find novel hits that do not exist in the dataset. We conduct a
literature search and find SkipGNN is able to discover novel hits. We select pairs that are not interacted
in the original dataset but are flagged as interaction from our model. We then pick the top 10 confident
interactions and feed them into literature database and see if there are evidence supporting our findings. We
find promising result for the DDI task (Table 5.6). Out of the 10 top-ranked interaction pairs, we are able to
find 6 pairs that have literature evidence support.
For example, for the interaction between Warfarin and Calozapine, Mukku et al. [2018] reports that
“Clozapine increase the concentrations of commonly used drugs in elderly like digoxin, heparin, phenytoin
andWarfarin by displacing them from plasma protein. This can lead to increase in respective adverse effects
with these medications.” Also, the manufacturer Novartis [1989] also reports that “Clozapinemay displace
Warfarin from plasma protein-binding sites. Increased levels of unboundWarfarin could result and could
increase the risk of hemorrhage.” Take another example between Warfarin and Ivacaftor, Robertson et al.
[2015] conducts a DDI study and reports that “caution and appropriate monitoring are recommended when
concomitant substrates of CYP2C9, CYP3A and/or P-gp are used during treatment with Ivacaftor, particularly
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drugs with a narrow therapeutic index, such asWarfarin.” Finally, we provide the top 10 outputs for DTI,
PPI, and GDI tasks in Appendix C.
6 Conclusion
We introduced SkipGNN, a novel graph neural network for predicting molecular interactions. The architec-
ture of SkipGNN is motivated by a principle of connectivity, which we call skip similarity. Remarkably, we
found that skip similarity allows SkipGNN to much better capture structural and evolutionary forces that
govern molecular interaction networks that what is possible with current graph neural networks. SkipGNN
achieves superior and robust performance on a variety of key prediction tasks in interaction networks and
performs well even when networks are highly incomplete.
There are several future directions. We focused here on networks in which all edges are of the same type.
As SkipGNN is a general graph neural network, it would be interesting to adapt SkipGNN to heterogeneous
networks, such as drug-gene-disease networks. Another fruitful direction would be to implement skip
similarity in other types of biological networks.
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A Experiments on the importance of each layer of GNN for
biomedical link prediction
To further support our claim on the importance of integrating skip similarity for GNN-based methods
on biomedical interaction network link prediction, we vary the architecture of vanilla GNN and perform
predictive comparison on DDI, PPI, and DTI tasks. Here are the variations:
• TwoLayers-OriGraph is the two layers GCN on original graph. It uses an indirect two-hops neigh-
borhood aggregation because the two-hops nodes information is conveyed to the center node through
the one-hop nodes.
• OneLayer-OriGraph is a one layer vanilla GCN. It only utilizes the immediate one-hop neighbor
information. Hence, it is a direct measure of direct similarity.
• TwoLayers-SkipGraph is the vanilla two layers GCN that operates on the skip graph. It uses direct
connection of center node with its two-hops neighborhood as against the indirect connection in vanilla
GCN. As it is two layer, it also considers indirect four-hops neighbor nodes.
• OneLayer-SkipGraph is the one layer version of GCN-A2. As it only uses two-hop neighbor infor-
mation, it directly measures the skip similarity.
Table A compares the results. From the large improvement of TwoLayers-OriGraph over OneLayer-
OriGraph, this is the initial evidence that two-hops neighborhood, which contains skip similarity node
relation assumption, is essential. Then, comparing OneLayer-OriGraph and OneLayer-SkipGraph, the
large margin improvement of OneLayer-SkipGraph implies two-hops neighbor alone has more predictive
information than one-hop neighbor alone, supporting our motivation analysis of the importance of skip
similarity for biomedical interaction network. Note also that the improvement from OneLayer-OriGraph
to TwoLayers-OriGraph is much larger than the improvement from OneLayer-SkipGraph to TwoLayers-
SkipGraph, meaning second-hop is essential and higher-order neighborhood is of limited importance for
interaction link prediction. Lastly, TwoLayers-OriGraph performs better than TwoLayers-SkipGraph,
meaning that biomedical interaction link prediction is a balance between immediate neighbor and two-hops
neighbor, confirming with our intuition that an ideal network should pursue a balance between them and
adding support for the iterative fusion scheme.
B Details about baseline methods
• L3 [Kovács et al., 2019] counts the length-3 paths among all the network nodes pairs. The number of
length-3 paths are then normalized by the degree of node pairs.
• DeepWalk [Perozzi et al., 2014] performs uniform distributed random walk and applies skip-gram
model to learn a node embedding. We use 20 walk lengths and then concatenate the target nodes
embedding with a logistic regression classifier.
• node2vec [Grover and Leskovec, 2016] builds on DeepWalk and uses biased random walk based on
depth/breath first search to consider both local and global network structure. We use 20 walk length
as the paper suggests longer walk lengths improve the embedding quality. The paper also reported
Hadamard product perform better than average and weighted L1/L2 for link prediction. However, in
our experiment, the simple concatenation is better than Hadamard. After the concatenation, we feed
into a logistic regression classifier as described in the paper.
• struc2vec [Ribeiro et al., 2017] leverages the local network structure in addition to the node2vec. We
use 80 walk length and 20 number of walks, following author’s recommendation. We then concatenate
the latent embedding and feed into a logistic regression classifier.
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Table 6: Skip Similarity is important for biomedical interaction prediction when using GCN. Results
of five independent runs on DDI, PPI and DTI tasks with varying architectures of GCN.
Task Method PR-AUC ROC-AUC
DTI
TwoLayers-OriGraph 0.904 ± 0.011 0.899 ± 0.010
OneLayer-OriGraph 0.807 ± 0.024 0.781 ± 0.026
TwoLayers-SkipGraph 0.849 ± 0.041 0.826 ± 0.052
OneLayer-SkipGraph 0.780 ± 0.047 0.756 ± 0.046
DDI
TwoLayers-OriGraph 0.856 ± 0.005 0.875 ± 0.004
OneLayer-OriGraph 0.810 ± 0.029 0.831 ± 0.029
TwoLayers-SkipGraph 0.848 ± 0.003 0.863 ± 0.002
OneLayer-SkipGraph 0.844 ± 0.008 0.862 ± 0.004
PPI
TwoLayers-OriGraph 0.909 ± 0.002 0.907 ± 0.006
OneLayer-OriGraph 0.806 ± 0.013 0.815 ± 0.015
TwoLayers-SkipGraph 0.900 ± 0.003 0.888 ± 0.004
OneLayer-SkipGraph 0.873 ± 0.023 0.863 ± 0.017
GDI
TwoLayers-OriGraph 0.909 ± 0.002 0.906 ± 0.006
OneLayer-OriGraph 0.846 ± 0.043 0.845 ± 0.039
TwoLayers-SkipGraph 0.888 ± 0.008 0.905 ± 0.007
OneLayer-SkipGraph 0.876 ± 0.016 0.883 ± 0.018
• Spectral Clustering [Tang and Liu, 2011] projects nodes on top-16 eigenvectors of the normalized
Laplacian matrix and uses the transposed eigenvectors as node embeddings. The embeddings are then
multiplied and pass through a sigmoid function to obtain link probabilities.
• VGAE [Kipf andWelling, 2016] applies variational graph auto-encoder and learns node embeddings that
best reconstruct the adjacent matrix. We use a two-layer GCN with hidden size 64 for layer one and 16
for layer two. The learning rate is set to be 5e-4 with Adam optimizer for 300 epochs. The dropout rate
is set to be 0.1.
• GCN [Kipf and Welling, 2017] uses two-layers GCN layers on original adjacency matrix to obtain node
embeddings, others are with same setting as SkipGNN . We use a two-layer GCN with hidden size 64
for layer one and 16 for layer two. The learning rate is set to be 5e-4 with Adam optimizer for 10 epochs
with batch size 256. SkipGNN usually converges within 5 epochs. The dropout rate is set to be 0.1.
We determine all parameters for the baseline methods using the grid search on a validation set.
C Potential novel hits for PPI, DTI, and GDI
We conducted a literature search for the DDI novel hits in the main text. Here, we also provide the novel
hits discovered through SkipGNN for the PPI, DTI, and GDI tasks in Table C.
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Table 7: Top-ranked novel predictions for PPI, DTI and GDI tasks. Potential novel hits for PPI, DTI,
GDI tasks. For long drug names, we use the DrugBank ID instead.




3 Glutamic acid NARS2
4 DB04530 CYP2D6


















Task Rank Gene Disease
GDI
1 RAPGEF3 Intellectual disability
2 ISL1 Intellectual disability
3 UHRF1BP1L Intellectual disability
4 RCN3 Intellectual disability
5 UGT1A4 Schizophrenia
6 DDX11 Schizophrenia
7 SOD2 Mental Retardation
8 IL1B Diabetes mellitus type 2
9 TNF Osteosarcoma
10 POMC Tactile Allodynia
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